0001209191-14-070835.txt : 20141124 0001209191-14-070835.hdr.sgml : 20141124 20141124165750 ACCESSION NUMBER: 0001209191-14-070835 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141120 FILED AS OF DATE: 20141124 DATE AS OF CHANGE: 20141124 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AUXILIUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001182129 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 233016883 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 640 LEE ROAD CITY: CHESTERBROOK STATE: PA ZIP: 19087 BUSINESS PHONE: 484 321 5900 MAIL ADDRESS: STREET 1: 640 LEE ROAD CITY: CHESTERBROOK STATE: PA ZIP: 19087 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tursi James Patrick CENTRAL INDEX KEY: 0001527710 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36628 FILM NUMBER: 141246913 MAIL ADDRESS: STREET 1: 640 LEE ROAD CITY: CHESTERBROOK STATE: PA ZIP: 19087 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-11-20 0 0001182129 AUXILIUM PHARMACEUTICALS INC AUXL 0001527710 Tursi James Patrick C/O AUXILIUM PHARMACEUTICALS, INC. 640 LEE ROAD CHESTERBROOK PA 19087 0 1 0 0 Chief Medical Officer Common Stock 2014-11-20 4 M 0 37500 14.10 A 76203 D Common Stock 2014-11-20 4 M 0 28500 19.51 A 104703 D Common Stock 2014-11-21 4 M 0 5000 22.04 A 109703 D Common Stock 2014-11-20 4 S 0 6200 32.9441 D 103503 D Common Stock 2014-11-20 4 S 0 59800 33.1751 D 43703 D Common Stock 2014-11-21 4 S 0 3648 33.446 D 40055 D Common Stock 2014-11-21 4 S 0 5000 33.4863 D 35055 D Nonqualified Stock Option (Right to Buy) 14.10 2014-11-20 4 M 0 37500 0.00 D 2012-08-08 2021-08-08 Common Stock 37500 12500 D Nonqualified Stock Option (Right to Buy) 19.51 2014-11-20 4 M 0 28500 0.00 D 2013-02-14 2022-02-13 Common Stock 28500 28500 D Nonqualified Stock Option (Right to Buy) 22.04 2014-11-21 4 M 0 5000 0.00 D 2012-02-17 2021-02-17 Common Stock 5000 4750 D Includes 498 shares acquired under the Auxilium Pharmaceuticals, Inc. 2006 Employee Stock Purchase Plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.925 to $32.97, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.10 to $33.32, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.40 to $33.525, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.38 to $33.53, inclusive. /s/ Michael J. Purvis, as attorney-in-fact on behalf of James P. Tursi, M.D. 2014-11-24